Marti Recort

Unit:

Chemistry & Molecular Pharmacology

Position:

Former - "Passa l\estiu"

Office:

EM01B11-12

Left IRB Barcelona in August 2017

Research Group

Research Unit on Asymmetric Synthesis

Cáncer

Selected group publications

Recent Advances in the Enantioselective Synthesis of Chiral Amines via Transition Metal-Catalyzed Asymmetric Hydrogenation

Cabré, A; Verdaguer, X; Riera, A

Chemical Reviews

122

(1 )

269 -

339

(2022)

Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease

Rol, A; Todorovski, T; Martin-Malpartida, P; Escolà, A; Gonzalez-Rey, E; Aragón, E; Verdaguer, X; Vallès-Miret, M; Farrera-Sinfreu, J; Puig, E; Fernández-Carneado, J; Ponsati, B; Delgado, M; Riera, A; Macias, MJ

Nature Communications

(1 )

1869 -

(2021)

Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Donoghue, C; Cubillos-Rojas, M; Gutierrez-Prat, N; Sanchez-Zarzalejo, C; Verdaguer, X; Riera, A; Nebreda, AR

European Journal Of Medicinal Chemistry

201

(- )

112451 -

(2020)

Synthesis and Application of 3-Bromo-1,2,4,5-Tetrazine for Protein Labeling to Trigger Click-to-Release Biorthogonal Reactions

Ros, E; Bellido, M; Verdaguer, X; de Pouplana, LR; Riera, A

Bioconjugate Chemistry

(3 )

933 -

938

(2020)

P-Stereogenic Amino-Phosphines as Chiral Ligands: From Privileged Intermediates to Asymmetric Catalysis

Cabré, A; Riera, A; Verdaguer, X

Accounts Of Chemical Research

(3 )

676 -

689

(2020)